◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

HomeAll stocksC › CTEC

Convatec Group PLC (CTEC) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Medical Instruments & Supplies · DATA UPDATED 2026-08-16

Convatec Group PLC (CTEC) operates in the Medical Instruments & Supplies industry and is headquartered in London, United Kingdom with about 10,000 employees. Its market capitalization is roughly $4 billion. In the fiscal year ended 2025-12-31, CTEC reported $2.4B in revenue and $175M in net income.

Convatec Group PLC engages in the development, manufacturing, and sale of medical products, services and technologies for the management of chronic conditions in Europe, North America, and internationally.

Interactive charts & full statements →

CTEC Revenue & Earnings History — Annual Income Statement

Income statement2025-12-312024-12-312023-12-312022-12-312021-12-31
Total Revenue$2.4B$2.3B$2.1B$2.1B
Gross Profit$1.4B$1.3B$1.2B$1.1B
Operating Income (EBIT)$386M$332M$265M$221M
Net Income$175M$191M$130M$63M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

CTEC Free Cash Flow History

Cash flow2025-12-312024-12-312023-12-312022-12-312021-12-31
Dividends Paid($140M)($130M)($111M)($88M)

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

CTEC Balance Sheet History

Balance sheet2025-12-312024-12-312023-12-312022-12-312021-12-31
Total Assets$3.8B$3.5B$3.7B$3.6B
Total Liabilities$2.3B$1.8B$2.0B$2.0B

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive CTEC viewer.

Other Companies in Medical Instruments & Supplies

← CTC.AAll “C” companiesCTEV →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.